Which people should take aspirin for primary prevention of cardiovascular disease?
Roberto Lozano,1 Maria-Esther Franco21Pharmacy Department, 2Haematology Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, SpainDear editorA single trial, ISIS-2,1 in 1988, demonstrated the utility of daily aspirin in the setting of acute myocardial infarction, reducing the...
Saved in:
Main Authors: | Lozano R (Author), Franco ME (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Which pill should we take?
by: Shanthi Ameratunga
Published: (2009) -
Which pill should we take?
by: Shanthi Ameratunga -
US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024) -
US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023) -
The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019)